Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12104/67437
Title: Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis
Author: Valle, Y.
Ledezma-Lozano, I.Y.
Torres-Carrillo, N.
Padilla-Gutierrez, J.R.
Navarro-Hernandez, R.E.
Vazquez-Del Mercado, M.
Palafox-Sanchez, C.A.
Armendariz-Borunda, J.
Munoz-Valle, J.F.
Issue Date: 2009
Abstract: Objective: To measure levels of soluble tumour necrosis factor alpha (TNF) receptor type I (sTNFRI) and type II (sTNFRII) in order to correlate them with C-reactive protein (CRP), rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), and disease activity score (DAS28) in RA patients. Methods: We recruited 41 RA patients classified according to American College of Rheumatology (ACR) criteria and 38 healthy subjects (HS). sTNFRI and sTNFRII were measured using an enzyme-linked immunosorbent assay (ELISA) kit. Clinical activity in RA patients was evaluated using the Disease Activity Score using 28 joint counts (DAS28). The statistical analysis was realized using SPSS version 10.0. Results: Soluble TNFRI and TNFRII levels were higher in RA patients (p = 0.04 and 0.001, respectively) than HS. Serum levels of sTNFRI correlated with sTNFRII (r = 0.699, p < 0.0001). sTNFRII correlated with DAS28 (r = 0.375, p = 0.017), RF (r = 0.505, p = 0.004), and ESR (r = 0.323, p = 0.042). Conclusion: The increased levels of both sTNFRI and sTNFRII suggest a secondary event related to the inflammatory state observed in RA, whereas the correlation of sTNFRII with RF, ESR, and DAS28 reflects the preferential TNFRII shedding induced by TNF. sTNFRII may be useful as an additional inflammatory marker in RA. © 2009 Taylor & Francis on license from Scandinavian Rheumatology Research Foundation.
URI: http://hdl.handle.net/20.500.12104/67437
Appears in Collections:Producción científica UdeG (prueba)

Files in This Item:
There are no files associated with this item.


Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.